Terms: = Bone cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
86 results:
1. TNF-α can promote membrane invasion by activating the MAPK/MMP9 signaling pathway through autocrine in bone-invasive pituitary adenoma.
Wu X; Gong L; Li B; Bai J; Li C; Zhang Y; Zhu H
CNS Neurosci Ther; 2024 May; 30(5):e14749. PubMed ID: 38739004
[TBL] [Abstract] [Full Text] [Related]
2. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.
Zhai M; Miao J; Zhang R; Liu R; Li F; Shen Y; Wang T; Xu X; Gao G; Hu J; He A; Bai J
J Cancer Res Clin Oncol; 2024 May; 150(5):239. PubMed ID: 38713252
[TBL] [Abstract] [Full Text] [Related]
3. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/erk pathway.
Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
[TBL] [Abstract] [Full Text] [Related]
4. IFNα-induced BST2
Zheng C; Wang J; Zhou Y; Duan Y; Zheng R; Xie Y; Wei X; Wu J; Shen H; Ye M; Kong B; Liu Y; Xu P; Zhang Q; Liang T
Cell Rep; 2024 Apr; 43(4):114088. PubMed ID: 38602878
[TBL] [Abstract] [Full Text] [Related]
5. Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells.
Li M; Zhang CL; Zhou DS; Chan SH; Liu XQ; Chen SN; Yang ZY; Ju FE; Sang XY; Liu ZX; Zhang QX; Pan YM; Deng SS; Wang XM; Zhong L; Zhang XD; Du X
Br J Haematol; 2024 Apr; 204(4):1307-1324. PubMed ID: 38462771
[TBL] [Abstract] [Full Text] [Related]
6. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and cancer Stemness through erk/NFκB axis in Osteosarcoma.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
[TBL] [Abstract] [Full Text] [Related]
7. Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via
Wang L; Bai X; Zhang X; Wang X; Chen S; Wu S; Lin L
Ann Clin Lab Sci; 2023 Nov; 53(6):920-930. PubMed ID: 38182151
[TBL] [Abstract] [Full Text] [Related]
8. Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking.
Liu MY; Jiang DX; Zhao X; Zhang L; Zhang Y; Liu ZD; Liu RZ; Li HJ; Rong XY; Gao YZ
Orthop Surg; 2024 Feb; 16(2):462-470. PubMed ID: 38086608
[TBL] [Abstract] [Full Text] [Related]
9. FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia.
Dobish KK; Wittorf KJ; Swenson SA; Bean DC; Gavile CM; Woods NT; Ghosal G; Hyde RK; Buckley SM
Leukemia; 2023 Nov; 37(11):2197-2208. PubMed ID: 37689825
[TBL] [Abstract] [Full Text] [Related]
10. TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/erk signaling.
Xia K; Zheng D; Wei Z; Liu W; Guo W
Cell Death Dis; 2023 Aug; 14(8):529. PubMed ID: 37591850
[TBL] [Abstract] [Full Text] [Related]
11. Identification of signature genes and drug candidates for primary plasma cell leukemia: An integrated system biology approach.
Chaudhary RK; Patil P; Ananthesh L; Gowdru Srinivasa M; Mateti UV; Shetty V; Khanal P
Comput Biol Med; 2023 Aug; 162():107090. PubMed ID: 37295388
[TBL] [Abstract] [Full Text] [Related]
12. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
Wang H; Li J; Li X
Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
[TBL] [Abstract] [Full Text] [Related]
13. Adamantinoma-Like Ewing Sarcoma Mimicking Merkel Cell Carcinoma in the Parotid Gland: A Diagnostic Pitfall.
Saikia K; Alruwaii FI; Wu V; Keller C; Chitale D; Al-Obaidy KI
Int J Surg Pathol; 2024 Feb; 32(1):115-118. PubMed ID: 37128815
[TBL] [Abstract] [Full Text] [Related]
14. FKBP11 improves the malignant property of osteosarcoma cells and acts as a prognostic factor of osteosarcoma.
Zeng D; Li J; Yuan X; Cai F; Yu B; Liu L; Chen Q; Zhang F; Liang Y; Tang X; Peng Y; Qu G; Wu P; Jiao Q; Sun L; Lv XB; Liao Q
Aging (Albany NY); 2023 Apr; 15(7):2450-2459. PubMed ID: 37014329
[TBL] [Abstract] [Full Text] [Related]
15. prognosis-related VDAC1 regulates the proliferation and apoptosis of osteosarcoma cells via the MAPK signaling pathway.
Cai X; Zhu S
Genomics; 2023 May; 115(3):110595. PubMed ID: 36871636
[TBL] [Abstract] [Full Text] [Related]
16. Ursonic acid inhibits migration and invasion of human osteosarcoma cells through the suppression of mitogen-activated protein kinases and matrix metalloproteinases.
Son J; Cha H; Lee S; Bae Y; Ryou C; Lee SY
Mol Biol Rep; 2023 May; 50(5):4029-4038. PubMed ID: 36848005
[TBL] [Abstract] [Full Text] [Related]
17. Dioscin induces osteosarcoma cell apoptosis by upregulating ROS-mediated p38 MAPK signaling.
Zheng GZ; Zhang QH; Chang B; Xie P; Liao H; Du SX; Li XD
Drug Dev Res; 2023 Feb; 84(1):25-35. PubMed ID: 36401839
[TBL] [Abstract] [Full Text] [Related]
18. Sorafenib inhibits doxorubicin-induced PD-L1 upregulation to improve immunosuppressive microenvironment in Osteosarcoma.
Wang J; Hu F; Yu P; Wang J; Liu Z; Bao Q; Zhang W; Wen J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5127-5138. PubMed ID: 36348018
[TBL] [Abstract] [Full Text] [Related]
19. Magnolol Suppresses erk/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma.
Li CH; Ku MC; Lee KC; Yueh PF; Hsu FT; Lin RF; Yang CC; Wang WC; Chen JH; Hsu LC; Lee YH
Anticancer Res; 2022 Sep; 42(9):4403-4410. PubMed ID: 36039427
[TBL] [Abstract] [Full Text] [Related]
20. Tsp2 Facilitates Tumor-associated Fibroblasts Formation and Promotes Tumor Progression in Retroperitoneal Liposarcoma.
Xu C; Yan L; Guan X; Wang Z; Wu J; Lv A; Liu D; Liu F; Dong B; Zhao M; Jia L; Tian X; Hao C
Int J Biol Sci; 2022; 18(13):5038-5055. PubMed ID: 35982904
[TBL] [Abstract] [Full Text] [Related]
[Next]